Ignite Creation Date:
2025-12-24 @ 5:45 PM
Ignite Modification Date:
2026-01-27 @ 5:02 PM
Study NCT ID:
NCT00335868
Status:
UNKNOWN
Last Update Posted:
2013-12-18
First Post:
2006-06-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CDR0000486219
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Ronald Paquette
Old Organization:
Jonsson Comprehensive Cancer Center at UCLA
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |